Cited by 197Nanoparticle-Based Drug DeliveryCharacterization and Applications of Magnetic NanoparticlesAdvanced Drug Delivery Systems

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields

Open access
Chorny, Michael, Fishbein, Ilia, Yellen, Benjamin B., Alferiev, Ivan S., Bakay, Marina, Ganta, Srinivas, Adamo, Richard, Amiji, Mansoor +2 more·2010·Proceedings of the National Academy of Sciences

Abstract

The use of stents for vascular disease has resulted in a paradigm shift with significant improvement in therapeutic outcomes. Polymer-coated drug-eluting stents (DES) have also significantly reduced the incidence of reobstruction post stenting, a disorder termed in-stent restenosis. However, the current DESs lack the capacity for adjustment of the drug dose and release kinetics to the disease status of the treated vessel. We hypothesized that these limitations can be addressed by a strategy combining magnetic targeting via a uniform field-induced magnetization effect and a biocompatible magnetic nanoparticle (MNP) formulation designed for efficient entrapment and delivery of paclitaxel (PTX). Magnetic treatment of cultured arterial smooth muscle cells with PTX-loaded MNPs caused significant cell growth inhibition, which was not observed under nonmagnetic conditions. In agreement with the results of mathematical modeling, significantly higher localization rates of locally delivered MNPs to stented arteries were achieved with uniform-field–controlled targeting compared to nonmagnetic controls in the rat carotid stenting model. The arterial tissue levels of stent-targeted MNPs remained 4- to 10-fold higher in magnetically treated animals vs. control over 5 days post delivery. The enhanced retention of MNPs at target sites due to the uniform field-induced magnetization effect resulted in a significant inhibition of in-stent restenosis with a relatively low dose of MNP-encapsulated PTX (7.5 μg PTX/stent). Thus, this study demonstrates the feasibility of site-specific drug delivery to implanted magnetizable stents by uniform field-controlled targeting of MNPs with efficacy for in-stent restenosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0909506107

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a follow-up study using the same experimental setup, magnetic nanoparticles loaded with paclitaxel for local delivery resulted in a substantial reduction in restenosis with low doses of paclitaxel.

    “In a follow-up study using the same experimental setup, the group used magnetic nanoparticles loaded with paclitaxel for local delivery, and they observed a substantial reduction in restenosis with low doses of paclitaxel103.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chorny, M., Fishbein, I., Yellen, B. B., Alferiev, I. S., Bakay, M., Ganta, S., Adamo, R., Amiji, M., Friedman, G., & Levy, R. J.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • Duke University (US)
  • Northeastern University (US)
  • Drexel University (US)
Corresponding author
Levy, Robert J.
Venue
Proceedings of the National Academy of Sciences
Published
2010-04-19
Volume
107
Issue
18
Pages
8346-8351
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2154590970
Cited by
197
References
30
Citations by year
2026: 4 · 2025: 6 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 12 · 2020: 6 · 2019: 10 · 2018: 13 · 2017: 17 · 2016: 18 · 2015: 8 · 2014: 20 · 2013: 16 · 2012: 21
FWCI
7.73
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Heart Association
  • Children's Hospital of Philadelphia
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (T32HL007915)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
drug-eluting stents, paclitaxel, magnetic nanoparticles, magnetic targeting, uniform magnetic field, in-stent restenosis, local drug delivery, arterial smooth muscle cells, carotid artery stenting, nanoparticle retention, vascular disease
MeSH terms
Animals, Cell Line, Graft Occlusion, Vascular, Magnetics, Male, Stents, Drug Delivery Systems, Rats, Sprague-Dawley, Paclitaxel, Microscopy, Electron, Transmission, Cell Proliferation, Rats, Metal Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review